Skip to main content

Table 2 Projected estimates associated with each scenario

From: Cost-effectiveness of early initiation of first-line combination antiretroviral therapy in Uganda

  Baseline CD4 count Start (Scenario A) Wait (Scenario B)
Life Expectancy, in years Lowest (250–259) 18.01 15.52
  Mean (250–350) 20.93 16.96
  Highest (340–350) 23.85 17.38
Discounted Life Expectancy, in years Lowest (250–259) 13.91 12.41
  Mean (250–350) 15.51 13.29
  Highest (340–350) 17.04 13.54
YLL Lowest (250–259)   1.50
  Mean (250–350)   2.23
  Highest (340–350)   3.49
YLD Lowest (250–259)   −0.17
  Mean (250–350)   −0.25
  Highest (340–350)   −0.39
DALY Lowest (250–259)   1.33
  Mean (250–350)   1.98
  Highest (340–350)   3.10
Lifetime Cost, cART + Monitoring Lowest (250–259) $4,255 $3,686
  Mean (250–350) $4,744 $3,885
  Highest (340–350) $5,210 $3,870
24 Months Hospitalization Cost Lowest (250–259) $45 $254
  Mean (250–350) $42 $389
  Highest (340–350) $38 $565
Net Cost Lowest (250–259) $4,300 $3,940
  Mean (250–350) $4,786 $4,274
  Highest (340–350) $5,248 $4,435
Cost per DALY Lowest (250–259) $270  
  Mean (250–350) $260  
  Highest (340–350) $262  
  1. cART- combination antiretroviral therapy; YLD – Years Lost due to Disability; DALY - Disability Adjusted Life Years.